Copper topical Pregnancy and Breastfeeding Warnings
Brand names: ParaGard
Copper topical Pregnancy Warnings
The intrauterine copper contraceptive has not been formally assigned to a pregnancy category by the FDA. Animal studies have not been conducted. There are no controlled data in human pregnancy. The intrauterine copper contraceptive should not be placed when a patient is pregnant or there is a suspicion of pregnancy.
If intrauterine pregnancy occurs with intrauterine copper contraceptive in place and the string is visible, intrauterine copper contraceptive should be removed because of the risk of spontaneous abortion, premature delivery, sepsis, septic shock, and, rarely, death. Removal may be followed by pregnancy loss.
The pregnancy rate in clinical studies has been less than 1 pregnancy per 100 women each year.
Copper topical Breastfeeding Warnings
No difference has been detected in concentration of copper in human milk before and after insertion of copper IUDs. Nursing mothers may use intrauterine copper contraceptive.
The literature is conflicting, but limited data suggest that there may be an increased risk of perforation and expulsion if a woman is lactating.
References for pregnancy information
- (2009) "Product Information. ParaGard (copper)." Barr Pharmaceuticals Inc
References for breastfeeding information
- (2009) "Product Information. ParaGard (copper)." Barr Pharmaceuticals Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
